ELI LILLY & Co is 235.6x more valuable than AMICUS THERAPEUTICS, INC. by market capitalization ($1.072 T vs $4.55 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | FOLD | LLY |
|---|---|---|
| Market cap | $4.55 B | $1.072 T |
| US-listed rank | #1468 | #10 |
| Revenue (latest FY) | $634.21M | $65.18B |
| Net income (latest FY) | -$27.11M | $20.64B |
| Net margin | -4.3% | 31.7% |
| P/E (trailing FY) | - | 51.9 |
| SEC filings | 2,171 | 989 |
ELI LILLY & Co is 235.6x more valuable than AMICUS THERAPEUTICS, INC. by market capitalization ($1.072 T vs $4.55 B).
In their latest fiscal years, AMICUS THERAPEUTICS, INC. reported $634.21M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: AMICUS THERAPEUTICS, INC. and ELI LILLY & Co, or browse the full rankings.